Brilliant perspective of #HCT and #CART therapies from Miguel Perales M.D. at #APBMT2023 opening cerimony ASTCT The EBMT Memorial Sloan Kettering Cancer Center #indonesia #semarang

Next up at #APBMT23 my good friend and former Memorial Sloan Kettering Cancer Center visiting investigator Alberto Mussetti MD Hematologia ICO Hospitalet discussing conditioning regimens #bmtsm

Aquí el resultado de la colaboración de múltiples centros ante el desabastecimiento de kits para extracción de médula ósea.
J M Portos Banc de Sang Sant Pau - Campus Salut Barcelona

onlinelibrary.wiley.com/doi/10.1111/vo…

Very nice and academic summary Alberto Mussetti MD Hematologia ICO Hospitalet Institut Català d'Oncologia #CoLym23 #Lymsm #Lymphoma #CARTcells

Today at #CoLym23 IACH
Alberto Mussetti MD “Prognostic factors for cellular therapy strategies” Hall B 9:55

Anna Sureda “CD19 autologous CART cells” Debate on 3rd line for #DLBCL . Hall B 17:00

Hematologia ICO Hospitalet Institut Català d'Oncologia #Lymsm #Lymphoma #CARTcell

✨New in Nature Medicine!

2nd line treatment with axi-cel #CARTcells resulted in high response rates and durable remissions in patients with transplant-ineligible large B-cell lymphoma.

Kudos to Roch Houot, Emmanuel Bachy, and the Lysa Lymphoma team!👏
nature.com/articles/s4159…

Great paper by the impressive French DESCAR-T registry outlining causes of NRM after CAR-T out in Blood Advances

➡️ Infections drive NRM after CAR-T

➡️ CAR-HEMATOTOX associated with overall NRM

Congrats to Emmanuel Bachy C. Thieblemont Roch Houot !

ashpublications.org/bloodadvances/…

Our last publication!!! The EBMT Marta Peña Annalisa Paviglianiti MD Lidia Hurtado Ortega itzi Clara Maluquer Eva Domingo-Domenech Eva Gonzalez Barca Alberto Mussetti MD Anna Sureda
Institut Català d'Oncologia IDIBELL

⬇️⬇️⬇️⬇️⬇️

nature.com/articles/s4140…

Patients diagnosed with r/r diffuse LBCL or high-grade B cell lymphoma may achieve prolonged survival following receipt of high-dose chemo/ #autoSCT or CD19-directed #CARTcell therapy. Early results show CART19 as second-line therapy results in improved OS. ow.ly/1ElN50PqeUc

In vivo hematopoietic stem cell modification by mRNA delivery | Science science.org/doi/10.1126/sc…

Spectrum of Antibiotics

Carlos Vázquez

A new article in the AI in Medicine series discusses the emerging use of AI in health care delivery; the use of AI in the domains of reimbursement, clinical operations, and quality and safety; and the challenges that health care organizations are facing in deploying AI.

Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T-cells ashpublications.org/blood/article-…

Novel developments in the prophylaxis and treatment of acute GVHD ashpublications.org/blood/article-…

Chemotherapy-induced reversal of ciltacabtagene autoleucel-associated movement and neurocognitive toxicity ashpublications.org/blood/article-…

astctjournal.org/article/S2666-…

nature.com/articles/d4158…

nature.com/articles/s4158…

nejm.org/doi/full/10.10…

A new guideline from ASTCT provides clinical practice recommendations for transplant and cellular therapies in diffuse large b-cell lymphoma. Review the #openaccess guideline: ow.ly/4VtQ50P9TuY Elsevier Hematology #LBCL Mehdi Hamadani, MD Narendranath Epperla